Shorts are getting desperate...
They might not be able to find patients to enroll in the phase 3 CRE superiority trial. At its earliest the cUTI trial will be done in 2 years.
It is a fact, just like your May 14 post saying "Trial results set to be revealed on the first business day of June."
Cidara Therapeutics. Phase 3 Party is a ways away but tide is low. Worth starting a small raft or just good for skipping stones?
Looks like an incredible bargain. Some of the employee reviews on Glassdoor say the company has a lot of contractor turnover however. Anyone checked that out?
Much respect to Betonbio, Trader 388 and the other longs here.
I'm thinking of taking out a loan to purchase more SGYP- already own 3k shares but opportunity calls. Just wanted to get some opinions about the potential patent weakness that user Frontiers brought to attention on investment hub. The concern is that Synergy's patent on composition is only based on a single amino acid modification and if discovered to happen in nature will invalidate their patent on Plecanatide.
The article's title is "Plecanatide versus Linaclotide : Impending Patent Disaster for the Synergy Partner" and it is a couple pages long.
I've been here all the time. I even bought 600 shares a few days ago when it was under $5.